XML 53 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurement (Tables)
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents for each of these hierarchy levels, the Company's financial assets and liabilities that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020:
(In thousands)Level ILevel IILevel IIITotal
At September 30, 2021:
Assets
Marketable securities8,190 — — 8,190 
Foreign currency derivatives— 300 — 300 
Liabilities
Interest rate swap contracts$— $575 $— $575 
Foreign currency derivatives — 3,491 — 3,491 
At December 31, 2020:
Assets
Cash equivalents
$107,494 $— $— $107,494 
Marketable securities
62,442 — — 62,442 
Foreign currency derivatives
— 667 — 667 
Liabilities
Interest rate swap contracts$— $2,403 $— $2,403 
Foreign currency derivatives — 3,515 — 3,515 
Schedule of Carrying Values and Fair Values of the Company's Financial Instruments
The carrying values and estimated fair values of the Company's financial instruments, excluding those that are carried at fair value in the condensed consolidated balance sheets, are summarized as follows:
(In thousands)September 30, 2021
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term loan A facility$663,912 $669,938 
5.00% Notes due April 2024
397,448 406,000 
4.75% Notes due August 2025
791,597 820,000 
4.25% Notes due February 2029
983,605 991,800 
Other debt1,500 1,500 
$2,838,062 $2,889,238 
(In thousands)December 31, 2020
Carrying
Amount
Estimated
Fair Value
Debt instruments:
Term loan A facility$669,878 $665,719 
4.75% Notes due December 2022
398,230 400,500 
5.00% Notes due April 2024
991,074 1,015,000 
4.75% Notes due August 2025
790,125 826,160 
$2,849,307 $2,907,379